Stereotactic Body Radiation Therapy for Early - Stage, Inoperable Non-Small Cell Lung Cancer
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 36 | Views: 250 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers | Radiotherapy & Oncology | India | Volume 10 Issue 1, January 2021 | Popularity: 6.4 / 10


     

Stereotactic Body Radiation Therapy for Early - Stage, Inoperable Non-Small Cell Lung Cancer

Ashith Conda, Pranav Chadha


Abstract: Although surgery continues to be the standard of care for early-stage NSCLC, SBRT appears to provide comparable local control and survival to lobectomy. Several ongoing randomized trials (Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR), Stablemates, and Radical Resection versus Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC (POSTILV) aim to answer this critical question of whether lobectomy or SBRT has superior tumor control and/or toxicity profile for early-stage operable NSCLC. Large amount of prospective data that lung SBRT is a highly effective and safe means by which to treat early-stage NSCLC.


Keywords: Lung, Non-Small Cell Carcinoma, Stereotactic Body Radiotherapy,


Edition: Volume 10 Issue 1, January 2021


Pages: 1187 - 1190


DOI: https://www.doi.org/10.21275/SR21120160058


Please Disable the Pop-Up Blocker of Web Browser

Type This Verification Code Below: 2716



Text copied to Clipboard!
Ashith Conda, Pranav Chadha, "Stereotactic Body Radiation Therapy for Early - Stage, Inoperable Non-Small Cell Lung Cancer", International Journal of Science and Research (IJSR), Volume 10 Issue 1, January 2021, pp. 1187-1190, https://www.ijsr.net/getabstract.php?paperid=SR21120160058, DOI: https://www.doi.org/10.21275/SR21120160058

Top